These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17455675)

  • 1. [Preventive measures for drug resistant bacteria by guidelines].
    Tomono K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():531-3. PubMed ID: 17455675
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs of choice for community-acquired bacterial pneumonia.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
    Matsushima T;
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():677-81. PubMed ID: 12722300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and treatment of pneumonia].
    Matsushima T
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():23-31. PubMed ID: 11989258
    [No Abstract]   [Full Text] [Related]  

  • 7. Community acquired pneumonia.
    Al-Qadi MO; Al-Alwan A; Opal SM; Cillley B; Silverblatt FJ
    Med Health R I; 2010 Jul; 93(7):196-200. PubMed ID: 20707009
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
    Ferrer M; Menendez R; Amaro R; Torres A
    Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of clinical pathways in infectious diseases].
    Ishida T
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():564-8. PubMed ID: 17455682
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal community-acquired pneumonia: pathogens and treatment.
    Wang H; Tang J; Xiong Y; Li X; Gonzalez F; Mu D
    J Paediatr Child Health; 2010 Nov; 46(11):668-72. PubMed ID: 20796185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating treatment according to resistance patterns and local epidemiology.
    J Assoc Physicians India; 2013 Jul; 61(7 Suppl):32-7. PubMed ID: 24779156
    [No Abstract]   [Full Text] [Related]  

  • 12. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 13. [The antibacterial therapy of community-acquired pneumonia].
    Khveshchuk PF; Rakov AL; Sinopal'nikov AI; Rudakova AV
    Voen Med Zh; 1999 Jan; 320(1):25-36. PubMed ID: 10200622
    [No Abstract]   [Full Text] [Related]  

  • 14. Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.
    Bartlett JG
    Semin Respir Infect; 1997 Dec; 12(4):329-33. PubMed ID: 9436960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(The JRS Guideline for the management of hospital-acquired pneumonia in adults)].
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2578-83. PubMed ID: 19051751
    [No Abstract]   [Full Text] [Related]  

  • 16. BTS guidelines for the management of community acquired pneumonia in adults: update 2009.
    Lim WS; Baudouin SV; George RC; Hill AT; Jamieson C; Le Jeune I; Macfarlane JT; Read RC; Roberts HJ; Levy ML; Wani M; Woodhead MA;
    Thorax; 2009 Oct; 64 Suppl 3():iii1-55. PubMed ID: 19783532
    [No Abstract]   [Full Text] [Related]  

  • 17. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
    Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
    Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline for nursing home acquired pneumonia (NHAP).
    Cunha BA
    Scand J Infect Dis; 2009; 41(1):77-8, author reply 76. PubMed ID: 18821134
    [No Abstract]   [Full Text] [Related]  

  • 19. Timely antibiotic therapy for community-acquired pneumonia.
    Mansel JK
    J Miss State Med Assoc; 2004 May; 45(5):159. PubMed ID: 15162706
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of bacteriological profile (aerobic) and antimicrobial susceptibility of community acquired pneumonia cases in the RIMS hospital.
    Vanlalruati RS; Mamta Devi KS; Singh NB; Singh NT
    J Commun Dis; 2012 Mar; 44(1):47-9. PubMed ID: 24455915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.